![Frank S. Menniti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank S. Menniti
Fondatore presso Mindimmune Therapeutics, Inc.
Profilo
Dr. Frank S.
Menniti is on the Board of Directors at Mindimmune Therapeutics, Inc.
Dr. Menniti was previously employed as Chief Scientific Officer by Luc Therapeutics, Inc.
Dr. Menniti received his undergraduate degree from Franklin & Marshall College, a graduate degree from Massachusetts Institute of Technology and a doctorate degree from the University of North Carolina at Chapel Hill.
Posizioni attive di Frank S. Menniti
Società | Posizione | Inizio |
---|---|---|
Mindimmune Therapeutics, Inc.
![]() Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI. | Fondatore | 12/07/2016 |
Precedenti posizioni note di Frank S. Menniti
Società | Posizione | Fine |
---|---|---|
Cadent Therapeutics, Inc.
![]() Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Fondatore | - |
Formazione di Frank S. Menniti
The University of North Carolina at Asheville | Doctorate Degree |
Franklin & Marshall College | Undergraduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Cadent Therapeutics, Inc.
![]() Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Mindimmune Therapeutics, Inc.
![]() Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mindimmune Therapeutics, Inc. develops drugs that target the immune system to treat diseases of the central nervous system. It focuses on the treatment of Alzheimer's, Huntington's disease, pain, and psychiatric disorders. The company was founded by Stevin Zorn, Frank S. Menniti, Robert B. Nelson, and Brian M. Campbell on July 12, 2016 and is headquartered in Kingston, RI. | Health Technology |
- Borsa valori
- Insiders
- Frank S. Menniti